Page last updated: 2024-10-27

fluoxetine and Osteosarcoma

fluoxetine has been researched along with Osteosarcoma in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, WT1
Tsai, YH1
Tan, P1
Hsu, FT1
Wang, HD1
Lin, WC1
Lin, FH1
Wu, CT1

Other Studies

1 other study available for fluoxetine and Osteosarcoma

ArticleYear
Fluoxetine Inhibits STAT3-mediated Survival and Invasion of Osteosarcoma Cells.
    Anticancer research, 2023, Volume: 43, Issue:3

    Topics: Adolescent; Apoptosis; Bone Neoplasms; Fluoxetine; Humans; Osteosarcoma; STAT3 Transcription Factor

2023